Lenalidomide

The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 12 is soliciting quotes for the purchase and delivery of Lenalidomide/Revlimid medication (brand name or equal) for pharmacy services at Tomah VA Medical Center. The solicitation requires the selected vendor to be certified in the Lenalidomide REMS program and capable of dispensing capsules in multiple dosages (2.5mg, 5mg, 10mg, 15mg, and 25mg) for treatment of multiple myeloma, myelodysplastic syndromes, mantle cell lymphoma, and follicular lymphoma. Key requirements include a complex prescription dispensing process with healthcare provider prescriptions, patient counseling, medication shipping with next-day delivery, signature confirmation, and capped shipping fees of $250. The contract will be awarded using a Lowest Price Technically Acceptable (LPTA) evaluation criterion. Quotes must be submitted via email to Contract Specialist Arneil Genus at arneil.genus@va.gov no later than December 29, 2025 at 3:00 PM CST, with only seven days available from the posting date for interested vendors to prepare and submit their proposals.

No set-aside designations have been applied to this procurement. The solicitation does not identify any incumbent contractors or current service providers. The specific award value or budget range has not been disclosed in the opportunity posting. The contract performance period is scheduled to run from January 5, 2026 to January 4, 2027, representing a one-year term for medication supply and pharmacy services. The place of performance is Tomah VA Medical Center in Tomah, Wisconsin 54660, with medication to be delivered either to the facility pharmacy or directly to patients as required by the VA facility.